Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tussovowen is a homeopathic complex preparation developed by Weber & Weber Biologische Arzneimittel, specifically formulated for the treatment of various types of cough and bronchial irritation. The product contains a synergistic blend of seven homeopathic active ingredients: *Bryonia*, *Coccus cacti*, *Cuprum aceticum*, *Drosera*, *Ipecacuanha*, *Spongia*, and *Sticta*. These components are traditionally selected in homeopathy to address symptoms such as dry, spasmodic coughs, chest tightness, and difficulty in expectoration. As a homeopathic medicine, Tussovowen is designed to stimulate the body's intrinsic healing mechanisms rather than suppressing symptoms through direct pharmacological inhibition. It is typically administered as oral drops and is indicated for use in both acute and chronic respiratory conditions involving cough and bronchitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tussovowen.